CONTEXT THERAPEUTICS INC (CNTX)
US21077P1084 - Common Stock
ChartMill assigns a Buy % Consensus number of 82% to CNTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.78. This target is 471.87% above the current price.
CNTX was analyzed by 10 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about CNTX.
In the previous month the buy percentage consensus was at a similar level.
CNTX was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-09-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-16 | Piper Sandler | Initiate | Overweight |
| 2024-05-09 | Maxim Group | Maintains | Buy -> Buy |
| 2024-05-09 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-21 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-01 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2023-09-11 | Maxim Group | Initiate | Buy |
| 2023-06-06 | HC Wainwright & Co. | Reiterate | Neutral |
| 2023-03-23 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-02-07 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-02-02 | HC Wainwright & Co. | Initiate | Buy |
| 2022-01-24 | ThinkEquity | Initiate | Buy |